Clinical Trials Directory

Trials / Conditions / Essential Thrombocythemia (ET)

Essential Thrombocythemia (ET)

12 registered clinical trials studyying Essential Thrombocythemia (ET) — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingMPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People
NCT07362225
MPN Research Foundation—
RecruitingMethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial
NCT06541249
Icahn School of Medicine at Mount SinaiPhase 2
Active Not RecruitingUnraveling the Role of Extracellular Vesicles-driven Senescence in Myeloproliferative Neoplasms
NCT06798805
IRCCS Azienda Ospedaliero-Universitaria di Bologna—
CompletedAssessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patient
NCT04243122
Ottawa Hospital Research InstitutePhase 2
RecruitingNational Longitudinal Cohort of Hematological Diseases
NCT04645199
Institute of Hematology & Blood Diseases Hospital, China—
Active Not RecruitingThe Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia
NCT02577926
RWTH Aachen UniversityPhase 2
CompletedAgrylin Drug Use-Result Survey
NCT03625895
Takeda—
CompletedScreening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negati
NCT01816256
University Health Network, TorontoN/A
CompletedExploratory Multi-centre Trial In Patients With ET Treated With XAGRID®
NCT01352585
Shire—
CompletedLong-term Safety of SPD422 in Japanese Adults With Essential Thrombocythaemia
NCT01467661
ShirePhase 3
CompletedEffect of SPD422 on Platelet Lowering and Safety in Japanese Adults With At Risk Essential Thrombocythaemia
NCT01214915
ShirePhase 3
CompletedPediatric Disease Registry in Essential Thrombocythaemia (ET)
NCT01198717
Shire—